Many Americans experience a “winter funk” as the days grow shorter and temperatures turn colder, a new American Psychiatric Association poll reports. Two-fifths of Americans (41%) said their mood declines during the winter months, according to the...

Eating fewer burgers and steaks could pay big dividends for Mother Earth, and human health, by combatting climate change, a new study suggests. Small cutbacks in beef production among wealthy nations could remove 125 billion tons of...

In 1972, Britain bumped up the total school years mandated for its children from 15 to 16 years. That created a “natural experiment”: Would Britons who got that extra year of education fare any better, neurologically, as...

Folks are more likely to drive drowsy than drive drunk, even though both raise the risk of a fatal crash, a new survey shows. About 4 in 10 adults say they’ll find alternative transportation when they haven’t...

More than a third of Americans continue to express mistrust in the science behind COVID vaccines, a new study finds. This level of mistrust has remained relatively consistent, expressed by 36% of people in 2021, 33% in...

Women who are pregnant but who also have the ovarian cyst disorder polycystic ovary syndrome (PCOS) are at higher odds of giving birth to an underweight baby, new Norwegian research shows. The risk rises even higher if...

In an early sign that the mpox outbreak in Africa might be ebbing, some health officials report that case counts seem to be stabilizing in the Congo, the epicenter of the outbreak. The World Health Organization first...

The omega-3 and omega-6 fatty acids in fish oil supplements might help protect people from cancer, a new study claims. Study participants with higher levels of omega-3s had lower rates of colon, stomach, lung and other digestive...

Canadian researchers have found that about 1 in every 3 people newly diagnosed with cancer experienced at least one emergency department visit sometime during the three months prior to their diagnosis. Many of the visits ended up...

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under...